Hyperemesis Gravidarum

Year 2017, Volume: 26 Issue: 3, 269 - 296, 30.09.2017

Mehmet Bülbül , Mustafa Kaplanoğlu , Emel Arslan Yıldırım Berna Yılmaz

https://doi.org/10.17827/aktd.303579

Cited By: 8

Abstract

Hyperemesis gravidarum is most commonly seen in the first trimester. Weight loss usually accompanies vomiting and it is less common that the pregnancy-related nausea (0.3-3.6%). Environmental factors and genetic predisposition may play a role in the etiology. Furthermore it is thought that the increased placental load and elevated β-hCG levels also play a role in development of hyperemesis gravidarum. The psychological state of the patient might also aggravate the disease. Hyperemesis gravidarum is diagnosed clinically. This situation will threaten the woman’s life besides having potential negative effects on the newborn health if it is not treated properly. The first step of treatment is diet and life style change. Intravenous hydration, electrolyte supplmentation and antiemetics can be used safely and efficiently..

Keywords

Hyperemesis gravidarum, etiology, treatment

Hiperemezis Gravidarum

Abstract

Hiperemezis gravidarum sıklıkla ilk trimesterde görülür. Kilo kaybı kusma ile birlikte seyreder ve gebeliğe bağlı bulantı-kusmaya göre daha nadirdir (%0,3-3.6). Çevresel faktörlerle genetik yatkınlığın etiyolojide rol oynadığı düşünülmektedir. Ayrıca plasental yük ve yüksek β-hCG düzeyleri de hiperemesis gravidarum gelişiminde rol oynar. Kişinin psikolojik yapısı da hastalığın seyrini değiştirebilir. Etiyolojide bunların dışında birçok faktör suçlansa da kanıtlanmış kesin bilgi yoktur. Hiperemesis gravidarum tanısı klinik olarak konulur. Uygun şekilde tedavi edilmediğinde anne ve bebeğin hayatını olumsuz etkileyebilir. Tedavide ilk basamak diyet ve yaşam tarzı değişikliğidir. İntravenöz hidrasyon, elektrolit desteği ile antiemetikler güvenli ve etkili olarak tedavide kullanılabilir.

Keywords

Hiperemezis gravidarum, Etiyoloji, Tedavi

References

• 1. Ismail SK, Kenny L. Review on hyperemesis gravidarum. Best Pract Res Clin Gastroenterol. 2007;21(5):755-69.
• 2. Fejzo MS, Poursharif B, Korst LM, Munch S, MacGibbon KW, Romero R, Goodwin TM. Symptoms and pregnancy outcomes associated with extreme weight loss among women with hyperemesis gravidarum. J Womens Health. 2009;18(12):1981-7.
• 3. Lee NM, Saha S. Nausea and vomiting of pregnancy. Gastroenterol Clin North Am. 2011;40(2):309-34.
• 4. Ayyavoo A, Derraik JG, Hofman PL, Biggs J, Bloomfield FH, Cormack BE, Stone P, Cutfield WS. Severe hyperemesis gravidarum is associated with reduced insulin sensitivity in the offspring in childhood. J Clin Endocrinol Metab. 2013;98(8):3263-8.
• 5. Bailit JL. Hyperemesis gravidarium: epidemiologic findings from a large cohort. Am J Obstet Gynecol 2005;193:811-4.
• 6. Adams MM, Harlass FE, Sarno AP, Read JA, Rawlings JS. Antenatal hospitalization among enlisted servicewomen, 1987-1990. Obstet Gynecol 1994;84:35-9.
• 7. Gazmararian JA, Petersen R, Jamieson DJ, Schild L, Adams MM, Deshpande AD, Franks AL. Hospitalizations during pregnancy among managed care enrollees. Obstet Gynecol 2002;100:94-100.
• 8. Einarson TR, Piwko C, Koren G. Quantifying the global rates of nausea and vomiting of pregnancy: a meta analysis. J Popul Ther Clin Pharmacol. 2013;20(2):171-83.
• 9. Källén B. Hyperemesis during pregnancy and delivery outcome: a registry study. Eur J Obstet Gynecol Reprod Biol. 1987;26(4):291-302.
• 10. Vandraas KF, Grjibovski AM, Støer NC, Troisi R, Stephansson O, Ording AG, Vangen S, Grotmol T, Vikanes ÅV. Hyperemesis gravidarum and maternal cancer risk, a Scandinavian nested case-control study. Int J Cancer. 2015;137(5):1209-16.
• 11. Einarson TR, Piwko C, Koren G. Prevalence of nausea and vomiting of pregnancy in the USA: a meta analysis. J Popul Ther Clin Pharmacol. 2013;20(2):163-70.
• 12. Matsuo K, Ushioda N, Nagamatsu M, Kimura T. Hyperemesis gravidarum in Eastern Asian population. Gynecol Obstet Invest. 2007;64(4):213-6.
• 13. Lacasse A, Rey E, Ferreira E, Morin C, Bérard A. Epidemiology of nausea and vomiting of pregnancy: prevalence, severity, determinants, and the importance of race/ethnicity. BMC Pregnancy Childbirth. 2009;2;9:26.
• 14. Klebanoff MA, Koslowe PA, Kaslow R, Rhoads GG. Epidemiology of vomiting in early pregnancy. Obstet Gynecol. 1985;66(5):612-6.
• 15. Heinrichs L. Linking olfaction with nausea and vomiting of pregnancy, recurrent abortion, hyperemesis gravidarum, and migraine headache. Am J Obstet Gynecol. 2002;186(5):215-9.
• 16. Corey LA, Berg K, Solaas MH, Nance WE. The epidemiology of pregnancy complications and outcome in a Norwegian twin population. Obstet Gynecol. 1992;80(6):989-94.
• 17. Hou JL1, Wan XR, Xiang Y, Qi QW, Yang XY. Changes of clinical features in hydatidiform mole: analysis of 113 cases. J Reprod Med. 2008;53(8):629-33.
• 18. Emelianova S, Mazzotta P, Einarson A, Koren G. Prevalence and severity of nausea and vomiting of pregnancy and effect of vitamin supplementation. Clin Invest Med. 1999;22(3):106-10.
• 19. Gill SK, Maltepe C, Koren G. The effect of heartburn and acid reflux on the severity of nausea and vomiting of pregnancy. Can J Gastroenterol. 2009;23(4):270-2.
• 20. Schiff MA, Reed SD, Daling JR. The sex ratio of pregnancies complicated by hospitalisation for hyperemesis gravidarum. BJOG. 2004;111(1):27-30.
• 21. Vikanes A, Skjaerven R, Grjibovski AM, Gunnes N, Vangen S, Magnus P. Recurrence of hyperemesis gravidarum across generations: population based cohort study. BMJ. 2010 Apr 29;340:2050.
• 22. Gadsby R, Barnie-Adshead AM, Jagger C. A prospective study of nausea and vomiting during pregnancy. Br J Gen Pract. 1993;43(371):245-8.
• 23. Rhodes VA, McDaniel RW. The Index of Nausea, Vomiting, and Retching: a new format of the lndex of Nausea and Vomiting. Oncol Nurs Forum. 1999;26(5):889-94.
• 24. Furneaux EC, Langley-Evans AJ, Langley-Evans SC. Nausea and vomiting of pregnancy: endocrine basis and contribution to pregnancy outcome. Obstet Gynecol Surv. 2001;56(12):775-82.
• 25. Verberg MF, Gillott DJ, Al-Fardan N, Grudzinskas JG. Hyperemesis gravidarum, a literature review. Hum Reprod Update. 2005;11(5):527-39.
• 26. Tamay AG, Kuşçu NK. Hyperemesis gravidarum: current aspect. J Obstet Gynaecol. 2011;31(8):708-12.
• 27. Lee NM, Saha S. Nausea and vomiting of pregnancy. Gastroenterol Clin North Am. 2011;40:309-34.
• 28. Sandven I, Abdelnoor M, Nesheim BI, Melby KK. Helicobacter pylori infection and hyperemesis gravidarum: a systematic review and meta-analysis of case-control studies. Acta Obstet Gynecol Scand. 2009;88:1190-200
• 29. Katon WJ, Ries RK, Bokan JA, Kleinman A. Hyperemesis gravidarum: a biopsychosocial perspective. Int J Psychiatry Med 1980;10: 151-62.
• 30. Leeners B, Sauer I, Rath W. Nausea and vomiting in early pregnancy/hyperemesis gravidarum. Current status of psychosomatic factors. Z Geburtshilfe Neonatol 2000;204:128-34.
• 31. Goodwin TM. Nausea and vomiting of pregnancy: an obstetric syndrome. AmJ Obstet Gynecol 2002;186:184-9.
• 32. Jewell D, Young G. Interventions for nausea and vomiting in early pregnancy. Cochrane Database Syst Rev 2003;4:CD000145.
• 33. Buckwalter JG, Simpson SW. Psychological factors in the etiology and treatment of severe nausea and vomiting in pregnancy. Am J Obstet Gynecol. 2002;186(5):210-4.
• 34. Matteson S, Roscoe J, Hickok J, Morrow GR. The role of behavioral conditioning in the development of nausea. Am J Obstet Gynecol. 2002;186(5):239-43.
• 35. Annagür BB, Tazegül A, Gündüz S. Do psychiatric disorders continue during pregnancy in women with hyperemesis gravidarum: a prospective study. Gen Hosp Psychiatry. 2013;35(5):492-6.
• 36. Magtira A, Schoenberg FP, MacGibbon K, Tabsh K, Fejzo MS. Psychiatric factors do not affect recurrence risk of hyperemesis gravidarum. J Obstet Gynaecol Res. 2015;41(4):512-6.
• 37. Goodwin TM, Montoro M, Mestman JH, Pekary AE, Hershman JM. The role of chorionic gonadotropin in transient hyperthyroidism of hyperemesis gravidarum. J Clin Endocrinol Metab. 1992;75(5):1333-7.
• 38. Verberg MF, Gillott DJ, Al-Fardan N, Grudzinskas JG. Hyperemesis gravidarum, a literature review. Hum Reprod Update. 2005;11(5):527-39.
• 39. Goodwin TM, Hershman JM, Cole L. Increased concentration of the free beta-subunit of human chorionic gonadotropin in hyperemesis gravidarum. Acta Obstet Gynecol Scand. 1994;73(10):770-2.
• 40. Wilson R, McKillop JH, MacLean M, Walker JJ, Fraser WD, Gray C, Dryburgh F, Thomson JA. Thyroid function tests are rarely abnormal in patients with severe hyperemesis gravidarum. Clin Endocrinol (Oxf). 1992;37(4):331-4.
• 41. Yoshimura M, Hershman JM. Thyrotropic action of human chorionic gonadotropin. Thyroid. 1995;5(5):425-34.
• 42. Vandraas KF, Vikanes ÅV, Støer NC, Vangen S, Magnus P, Grjibovski AM. Is hyperemesis gravidarum associated with placental weight and the placental weight-to-birth weight ratio? A population-based Norwegian cohort study. Placenta. 2013;34(11):990-4.
• 43. Tülek F, Kahraman A, Taşkın S, Özkavukçu E, Söylemez F. Changes in first trimester screening test parameters in pregnancies complicated by placenta previa and association with hyperemesis gravidarum. J Turk Ger Gynecol Assoc. 2014;15(4):212-6.
• 44. Niemeijer MN, Grooten IJ, Vos N, Bais JM, van der Post JA, Mol BW, Roseboom TJ, Leeflang MM, Painter RC. Diagnostic markers for hyperemesis gravidarum: a systematic review and metaanalysis. Am J Obstet Gynecol. 2014;211(2):150.1-15.
• 45. Sun S, Qiu X, Zhou J. Clinical analysis of 65 cases of hyperemesis gravidarum with gestational transient thyrotoxicosis. J Obstet Gynaecol Res. 2014;40(6):1567-72.
• 46. Lagiou P, Tamimi R, Mucci LA, Trichopoulos D, Adami HO, Hsieh CC. Nausea and vomiting in pregnancy in relation to prolactin, estrogens, and progesterone: a prospective study. Obstet Gynecol. 2003;101(4):639-44.
• 47. Helseth R, Ravlo M, Carlsen SM, Vanky EE. Androgens and hyperemesis gravidarum: a case-control study. Eur J Obstet Gynecol Reprod Biol. 2014;175:167-71.
• 48. Cengiz H, Dagdeviren H, Caypinar SS, Kanawati A, Yildiz S, Ekin M. Plasma serotonin levels are elevated in pregnant women with hyperemesis gravidarum. Arch Gynecol Obstet. 2015;291(6):1271-6.
• 49. Borgeat A, Fathi M, Valiton A. Hyperemesis gravidarum: is serotonin implicated? Am J Obstet Gynecol. 1997;176(2):476-7.
• 50. Chou FH, Chan TF, Chin CC, Chen YL, Shen CJ, Kuo SH. Biomarkers and perceived emotional stress in early-stage pregnant taiwanese women with nausea and vomiting. Biol Res Nurs. 2011;13(4):351-6.
• 51. Aka N, Atalay S, Sayharman S, Kiliç D, Köse G, Küçüközkan T. Leptin and leptin receptor levels in pregnant women with hyperemesis gravidarum. Aust N Z J Obstet Gynaecol. 2006;46(4):274-7.
• 52. Arslan EO, Cengiz L, Arslan M. Thyroid function in hyperemesis gravidarum and correlation with serum leptin levels. Int J Gynaecol Obstet. 2003;83(2):187-8.
• 53. Unsel N, Benian A, Erel CT. Leptin levels in women with hyperemesis gravidarum. Int J Gynaecol Obstet. 2004;84(2):162-3.
• 54. Demir B, Erel CT, Haberal A, Oztürk N, Güler D, Koçak M. Adjusted leptin level (ALL) is a predictor for hyperemesis gravidarum. Eur J Obstet Gynecol Reprod Biol. 2006;124(2):193-6.
• 55. Mansour GM, Nashaat EH. Role of Helicobacter pylori in the pathogenesis of hyperemesis gravidarum. Arch Gynecol Obstet. 2011;284(4):843-7.
• 56. Golberg D, Szilagyi A, Graves L. Hyperemesis gravidarum and Helicobacter pylori infection: a systematic review. Obstet Gynecol. 2007;110(3):695-703.
• 57. El Younis CM, Abulafia O, Sherer DM. Rapid marked response of severe hyperemesis gravidarum to oral erythromycin. Am J Perinatol. 1998;15(9):533-4.
• 58. Jacoby EB, Porter KB. Helicobacter pylori infection and persistent hyperemesis gravidarum. Am J Perinatol. 1999;16(2):85-8.
• 59. Karadeniz RS, Ozdegirmenci O, Altay MM, Solaroglu A, Dilbaz S, Hizel N, Haberal A. Helicobacter pylori seropositivity and stool antigen in patients with hyperemesis gravidarum. Infect Dis Obstet Gynecol. 2006;2006:73073.
• 60. Brzana RJ, Koch KL. Gastroesophageal reflux disease presenting with intractable nausea. Ann Intern Med. 1997;126(9):704-7.
• 61. Fejzo MS, Ingles SA, Wilson M, Wang W, MacGibbon K, Romero R, Goodwin TM. High prevalence of severe nausea and vomiting of pregnancy and hyperemesis gravidarum among relatives of affected individuals. Eur J Obstet Gynecol Reprod Biol. 2008;141(1):13-7.
• 62. Trogstad LI, Stoltenberg C, Magnus P, Skjaerven R, Irgens LM. Recurrence risk in hyperemesis gravidarum. BJOG. 2005;112(12):1641-5..
• 63. Outlaw WM, Ibdah JA. Impaired fatty acid oxidation as a cause of liver disease associated with hyperemesis gravidarum. Med Hypotheses. 2005;65(6):1150-3.
• 64. Innes AM, Seargeant LE, Balachandra K, Roe CR, Wanders RJ, Ruiter JP, Casiro O, Grewar DA, Greenberg CR. Hepatic carnitine palmitoyltransferase I deficiency presenting as maternal illness in pregnancy. Pediatr Res. 2000;47(1):43-5.
• 65. Engin-Ustun Y, Tonguç E, Var T, Deveer R, Yilmaz N, Danisman N, Besli M, Mollamahmutoglu L. Vaspin and C-reactive protein levels in hyperemesis gravidarum. Eur Rev Med Pharmacol Sci. 2013;17(1):138-40.
• 66. Yilmaz S, Ozgu-Erdinc AS, Demirtas C, Ozturk G, Erkaya S, Uygur D. The oxidative stress index increases among patients with hyperemesis gravidarum but not in normal pregnancies. Redox Rep. 2015;20(3):97-102.
• 67. Kurt RK, Güler A, Silfeler DB, Ozçil MD, Karateke A, Hakverdi AU. Relation of inflammatory markers with both presence and severity of hyperemesis gravidarum. Ginekol Pol. 2014;85(8):589-93.
• 68. Biberoglu E, Kirbas A, Iskender C, Dirican A, Daglar H, Demirtas C, Doganay B, Uygur D, Biberoglu K. Disturbed release of cholecystokinin in pregnant women with hyperemesis gravidarum. J Obstet Gynaecol Res. 2015;41(4):505-11.
• 69. Goodwin TM. Hyperemesis gravidarum. Obstet Gynecol Clin North Am. 2008 Sep;35(3):401-17.
• 70. http://www.helpher.org/. Accessed Dec. 10, 2013.
• 71. Koren G, Boskovic R, Hard M, Maltepe C, Navioz Y, Einarson A. Motherisk-PUQE (pregnancy-unique quantification of emesis and nausea) scoring system for nausea and vomiting of pregnancy. Am J Obstet Gynecol 2002;186:S228–31
• 72. Lacasse A, Rey E, Ferreira E, Morin C, Be´ rard A. Validity of a modified Pregnancy-Unique Quantification of Emesis and Nausea (PUQE) scoring index to assess severity of nausea and vomiting of pregnancy. Am J Obstet Gynecol 2008;198(1):71.1–7.
• 73. Herrell HE. Nausea and vomiting of pregnancy. Am Fam Physician. 2014;89(12):965-70.
• 74. Reid DE, Teel HM. The treatment of the vomiting of early pregnancy. N Engl J Med. 1938;218:109-13
• 75. Paauw JD, Bierling S, Cook CR, Davis AT. Hyperemesis gravidarum and fetal outcome. JPEN J Parenter Enteral Nutr. 2005;29(2):93-6.
• 76. Di Gangi S, Gizzo S, Patrelli TS, Saccardi C, D'Antona D, Nardelli GB. Wernicke's encephalopathy complicating hyperemesis gravidarum: from the background to the present. J Matern Fetal Neonatal Med. 2012;25(8):1499-504.
• 77. Chiossi G, Neri I, Cavazzuti M et al. Hyperemesis gravidarum complicated by Wernicke encephalopathy: background, case report, and review of the literature. Obstet Gynecol Surv. 2006;61(4): 255–268
• 78. Zuccoli G, Gallucci M, Capellades J, Regnicolo L, Tumiati B, Giadás TC, Bottari W, Mandrioli J, Bertolini M. Wernicke encephalopathy: MR findings at clinical presentation in twenty-six alcoholic and nonalcoholic patients. AJNR Am J Neuroradiol. 2007;28(7):1328-31
• 79. Bergin PS & Harvey P. Wernicke’s encephalopathy and central pontine myelinolysis associated with hyperemesis gravidarum. Br Med J. 1992;305(6852): 517–518.
• 80. Peeters A, Van de Wyngaert F, Van Lierde M et al. Wernicke’s encephalopathy and central pontine myelinolysis induced by hyperemesis gravidarum. Acta Neurol Belg. 1993; 93(5): 276–282.
• 81. Burneo J, Vizcarra D & Miranda H. Central pontine myelinolysis and pregnancy: a case report and review of literature. Rev Neurol. 2000;30(11):1036–1040
• 82. Swallow BL, Lindow SW, Masson EA, Hay DM. Psychological health in early pregnancy: relationship with nausea and vomiting. J Obstet Gynaecol. 2004;24(1):28-32.
• 83. Brasky TM, Li Y, Jaworowicz DJ Jr., et al. Pregnancy-related characteristics and breast cancer risk. Cancer Causes Control. 2013;24:1675–85.
• 84. Enger SM, Ross RK, Henderson B, et al. Breastfeeding history, pregnancy experience and risk of breast cancer. Br J Cancer. 997;76:118–23.
• 85. Jorgensen KT, Nielsen NM, Pedersen BV, et al. Hyperemesis, gestational hypertensive disorders, pregnancy losses and risk of autoimmune diseases in a danish population-based cohort. J Autoimmun. 2012;38:J120–8.
• 86. Sherman PW, Flaxman SM. Nausea and vomiting of pregnancy in an evolutionary perspective. Am J Obstet Gynecol. 2002;186(5):190-7.
• 87. Flaxman SM, Sherman PW. Morning sickness: a mechanism for protecting mother and embryo. Q Rev Biol. 2000;75(2):113-48.
• 88. Huxley RR. Nausea and vomiting in early pregnancy: its role in placental development. Obstet Gynecol. 2000;95(5):779-82.
• 89. Nulman I, Rovet J, Barrera M, Knittel-Keren D, Feldman BM, Koren G. Long-term neurodevelopment of children exposed to maternal nausea and vomiting of pregnancy and diclectin. J Pediatr. 2009;155(1):45-50, 50.1-2.
• 90. Czeizel AE, Puhó E. Association between severe nausea and vomiting in pregnancy and lower rate of preterm births. Paediatr Perinat Epidemiol. 2004;18(4):253-9.
• 91. Weigel RM, Weigel M. Nausea and vomiting of early pregnancy and pregnancy outcome: a meta-analytical review. BJOG. 1989;96:1312-8
• 92. Vikanes ÅV, Støer NC, Magnus P, Grjibovski AM. Hyperemesis gravidarum and pregnancy outcomes in the Norwegian Mother and Child Cohort - a cohort study. BMC Pregnancy Childbirth. 2013;13:169.
• 93. Vandraas KF, Vikanes AV, Vangen S, Magnus P, Støer NC, Grjibovski AM. Hyperemesis gravidarum and birth outcomes-a population-based cohort study of 2.2 million births in the Norwegian Birth Registry. BJOG. 2013;120(13):1654-60.
• 94. Veenendaal MV, van Abeelen AF, Painter RC, van der Post JA, Roseboom TJ. Consequences of hyperemesis gravidarum for offspring: a systematic review and meta-analysis. BJOG. 2011;118(11):1302-13.
• 95. Czeizel AE, Sárközi A, Wyszynski DF. Protective effect of hyperemesis gravidarum for nonsyndromic oral clefts. Obstet Gynecol. 2003;101(4):737-44.
• 96. Roseboom TJ, Ravelli AC, van der Post JA, Painter RC. Maternal characteristics largely explain poor pregnancy outcome after hyperemesis gravidarum. Eur J Obstet Gynecol Reprod Biol. 2011;156(1):56-9.
• 97. Bolin M, Åkerud H, Cnattingius S, Stephansson O, Wikström AK. Hyperemesis gravidarum and risks of placental dysfunction disorders: a population-based cohort study. BJOG. 2013;120(5):541-7.
• 98. Buyukkayaci Duman N, Ozcan O, Bostanci MÖ. Hyperemesis gravidarum affects maternal sanity, thyroid hormones and fetal health: a prospective case control study. Arch Gynecol Obstet. 2015;292(2):307-12.
• 99. Lu QB, Wang ZP2, Gao LJ2, Gong R2, Sun XH2, Wang M2, Zhao ZT2.Nausea and vomiting in early pregnancy and the risk of neural tube defects: a case-control study. Sci Rep. 2015;5:7674.
• 100. Mullin P, Bray A, Schoenberg F, et al. Prenatal exposure to hyperemesis gravidarum linked to increased risk of psychological and behavioral disorders in adulthood. J Dev Orig Health Dis. 2011;2:200-4.
• 101. Zhu MJ, Ford SP, Means WJ, Hess BW, Nathanielsz PW, Du M. Maternal nutrient restriction affects properties of skeletal muscle in offspring. J Physiol. 2006;575:241-50.
• 102. Guo Z, Zhou L. Evidence for increased and insulin-resistant lipolysis in skeletal muscle of high-fat-fed rats. Metabolism. 2004;53:794-8.
• 103. Grooten I, Painter R, Pontesilli M, van der Post J, Mol B, van Eijsden M, Vrijkotte T, Roseboom T. Weight loss in pregnancy and cardiometabolic profile in childhood: findings from a longitudinal birth cohort. BJOG. 2015;122(12):1664-73
• 104. Ayyavoo A, Derraik JG, Hofman PL, Cutfield WS. Hyperemesis gravidarum and long-term health of the offspring. Am J Obstet Gynecol. 2014;210(6):521-5.
• 105. Piwko C, Koren G, Babashov V, Vicente C, Einarson TR. Economic burden of nausea and vomiting of pregnancy in the USA. J Popul Ther Clin Pharmacol. 2013;20(2):149-60.
• 106. American College of Obstetrics and Gynecology. ACOG (American College of Obstetrics and Gynecology) Practice Bulletin: nausea and vomiting of pregnancy. Obstet Gynecol. 2004;103(4):803-14.
• 107. Mazzotta P, Magee LA. A risk-benefit assessment of pharmacological and nonpharmacological treatments for nausea and vomiting of pregnancy. Drugs. 2000;59(4):781-800.
• 108. Magee LA, Mazzotta P, Koren G. Evidence-based view of safety and effectiveness of pharmacologic therapy for nausea and vomiting of pregnancy (NVP). Am J Obstet Gynecol. 2002;186(5):256-61.
• 109. Källén B. Use of antihistamine drugs in early pregnancy and delivery outcome. J Matern Fetal Neonatal Med. 2002;11(3):146-52.
• 110. McKeigue PM, Lamm SH, Linn S, Kutcher JS. Bendectin and birth defects: I. A meta-analysis of the epidemiologic studies. Teratology. 1994;50(1):27-37.
• 111. Asker C, Norstedt Wikner B, Källén B. Use of antiemetic drugs during pregnancy in Sweden. Eur J Clin Pharmacol. 2005;61(12):899-906.
• 112. Goodwin TM, Poursharif B, Korst LM, MacGibbon KW, Romero R, Fejzo MS. Secular trends in the treatment of hyperemesis gravidarum. Am J Perinatol. 2008;25(3):141-7.
• 113. Oliveira LG, Capp SM, You WB, Riffenburgh RH, Carstairs SD. Ondansetron compared with doxylamine and pyridoxine for treatment of nausea in pregnancy: a randomized controlled trial. Obstet Gynecol. 2014;124(4):735-42.
• 114. Abas MN, Tan PC, Azmi N, Omar SZ. Ondansetron compared with metoclopramide for hyperemesis gravidarum: a randomized controlled trial. Obstet Gynecol. 2014;123(6):1272-9.
• 115. Maina A, Arrotta M, Cicogna L, Donvito V, Mischinelli M, Todros T, Rivolo S. Transdermal clonidine in the treatment of severe hyperemesis. A pilot randomised control trial: CLONEMESI. BJOG. 2014;121(12):1556-62.
• 116. Safari HR, Fassett MJ, Souter IC, Alsulyman OM, Goodwin TM. The efficacy of methylprednisolone in the treatment of hyperemesis gravidarum: a randomized, double-blind, controlled study. Am J Obstet Gynecol. 1998;179(4):921-4
• 117. Safari HR, Alsulyman OM, Gherman RB, Goodwin TM. Experience with oral methylprednisolone in the treatment of refractory hyperemesis gravidarum. Am J Obstet Gynecol. 1998;178(5):1054-8.
• 118. Yost NP, McIntire DD, Wians FH Jr, Ramin SM, Balko JA, Leveno KJ. A randomized, placebo-controlled trial of corticosteroids for hyperemesis due to pregnancy. Obstet Gynecol. 2003;102(6):1250-4.
• 119. Willetts KE, Ekangaki A, Eden JA. Effect of a ginger extract on pregnancy-induced nausea: a randomised controlled trial. Aust N Z J Obstet Gynaecol. 2003;43(2):139-44.
• 120. Borrelli F, Capasso R, Aviello G, Pittler MH, Izzo AA. Effectiveness and safety of ginger in the treatment of pregnancy-induced nausea and vomiting. Obstet Gynecol. 2005;105(4):849-56.
• 121. Ozgoli G, Goli M, Simbar M. Effects of ginger capsules on pregnancy, nausea, and vomiting. J Altern Complement Med. 2009;15(3):243-6.
• 122. Smith C, Crowther C, Willson K, Hotham N, McMillian V. A randomized controlled trial of ginger to treat nausea and vomiting in pregnancy. Obstet Gynecol. 2004;103(4):639-45.
• 123. Chittumma P, Kaewkiattikun K, Wiriyasiriwach B. Comparison of the effectiveness of ginger and vitamin B6 for treatment of nausea and vomiting in early pregnancy: a randomized double-blind controlled trial. J Med Assoc Thai. 2007;90(1):15-20.
• 124. Ensiyeh J, Sakineh MA. Comparing ginger and vitamin B6 for the treatment of nausea and vomiting in pregnancy: a randomised controlled trial. Midwifery. 2009;25(6):649-53.
• 125. Guttuso T Jr, Roscoe J, Griggs J. Effect of gabapentin on nausea induced by chemotherapy in patients with breast cancer. Lancet. 2003b;361:1703–1705
• 126. Guttuso T Jr. Gabapentin's anti-nausea and anti-emetic effects: a review. Exp Brain Res. 2014;232(8):2535-9.
• 127. Guttuso T Jr, Shaman M, Thornburg LL. Potential maternal symptomatic benefit of gabapentin and review of its safety in pregnancy. Eur J Obstet Gynecol Reprod Biol. 2014;181:280-3.
• 128. Sahakian V, Rouse D, Sipes S, Rose N, Niebyl J. Vitamin B6 is effective therapy for nausea and vomiting of pregnancy: a randomized, double-blind placebo-controlled study. Obstet Gynecol. 1991;78(1):33-6.
• 129. Vutyavanich T, Wongtra-ngan S, Ruangsri R. Pyridoxine for nausea and vomiting of pregnancy: a randomized, double-blind, placebo-controlled trial. Am J Obstet Gynecol. 1995;173(3 Pt 1):881-4.
• 130. Vaisman N, Kaidar R, Levin I, Lessing JB. Nasojejunal feeding in hyperemesis gravidarum--a preliminary study. Clin Nutr. 2004;23(1):53-7.
• 131. Stokke G, Gjelsvik BL, Flaatten KT, Birkeland E, Flaatten H, Trovik J. Hyperemesis gravidarum, nutritional treatment by nasogastric tube feeding: a 10-year retrospective cohort study. Acta Obstet Gynecol Scand. 2015;94(4):359-67.
• 132. Puangsricharern A, Mahasukhon S. Effectiveness of auricular acupressure in the treatment of nausea and vomiting in early pregnancy. J Med Assoc Thai. 2008;91(11):1633-8
• 133. Matthews A, Dowswell T, Haas DM, Doyle M, O'Mathúna DP. Interventions for nausea and vomiting in early pregnancy. Cochrane Database Syst Rev. 2010 Sep 8;(9):CD007575.
• 134. Smith C, Crowther C, Beilby J. Acupuncture to treat nausea and vomiting in early pregnancy: a randomized controlled trial. Birth. 2002;29(1):1-9.
• 135. Knight B, Mudge C, Openshaw S, White A, Hart A. Effect of acupuncture on nausea of pregnancy: a randomized, controlled trial. Obstet Gynecol. 2001;97(2):184-8.
• 136. Matthews A, Haas DM, O'Mathúna DP, Dowswell T, Doyle M. Interventions for nausea and vomiting in early pregnancy. Cochrane Database Syst Rev. 2014 Mar 21;3:CD007575.
• 137. Henker FO 3rd. Psychotherapy as adjunct in treatment of vomiting during pregnancy. South Med J. 1976;69(12):1585-7.
• 138. Zechnich R, Hammer T. Brief psychotherapy for hyepremesis gravidarum. Am Fam Physician. 1982;26(5):179-81.
• 139. http://www.uptodate.com/home/grading-guide.